Abstract
In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Current Bioinformatics
Title:Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data
Volume: 9 Issue: 5
Author(s): Lian En Chai, Mohd Saberi Mohamad, Safaai Deris, Chuii Khim Chong, Yee Wen Choon and Sigeru Omatu
Affiliation:
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Abstract: In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Export Options
About this article
Cite this article as:
Chai En Lian, Mohamad Saberi Mohd, Deris Safaai, Chong Khim Chuii, Choon Wen Yee and Omatu Sigeru, Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140421210333
DOI https://dx.doi.org/10.2174/1574893609666140421210333 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effects of Trifluoromethylated Derivatives on Prostaglandin E<sub>2</sub> and Thromboxane A<sub>2</sub> Production in Human Leukemic U937 Macrophages
Medicinal Chemistry The Role of microRNA in Ischemic and Hemorrhagic Stroke
Current Drug Delivery Nanofibers: New Insights for Drug Delivery and Tissue Engineering
Current Topics in Medicinal Chemistry Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers
Anti-Cancer Agents in Medicinal Chemistry Effective Strategies and Applications of Dendrimers in the Treatment of Ovarian Cancer
Current Pharmaceutical Design Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets Cross Talks Between Oncoprotein Signaling Networks and Tumor Suppressor p53 in Breast Cancer
Current Cancer Therapy Reviews Molecular Imaging with Nucleic Acid Aptamers
Current Medicinal Chemistry Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Regulation and Quantification of Cellular Mitochondrial Morphology and Content
Current Pharmaceutical Design Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
Current Cancer Drug Targets The Proteasome in Health and Disease
Current Pharmaceutical Design Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Identification of New Pancreatic Beta Cell Targets for In Vivo Imaging by a Systems Biology Approach
Current Pharmaceutical Design Molecular Profiling - An Essential Technology Enabling Personalized Medicine in Breast Cancer
Current Drug Targets Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) – A Critical Review
Current Medicinal Chemistry Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Current Medicinal Chemistry Applied Proteomics in Companion Animal Medicine
Current Proteomics Bicycloheptylamine-Doxorubicin Conjugate: Synthesis and Anticancer Activities in σ2 Receptor-Expressing Cell Lines
Medicinal Chemistry